Based on the available data, the American College of Rheumatology currently recommends that TNF alpha inhibitors should be cautiously used in patients with CHF, especially in those with a reduced ejection fraction of approximately 40 percent from a healthy ejection fraction of between 50 and 70 percent [26]. This evidence concerns the gene TNF and congestive heart failure.